He talks about it because his clinical team has used it widely for joint, tendon, and gut issues, with no reported adverse events in their patient base
Encouraged by these results, Sekhar has continued his investigations by testing the value of GlyNAC supplementation for improving the health of the growing older population, and has completed an open label trial, and another NIH-funded, double-blind, placebo-controlled trial in older adults
Safety profile : What are the contraindications
(2) FOXO4-DRI peptide competitively blocked this FOXO4-p53 interaction
But I just don't see some of these narratives being super helpful overall, because it gets people focused on the wrong stuff, and it's just a very confusing overall narrative
We went all out: Monster Energy